Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 11, Issue 1, 2008, Pages 40-45

  Chin, J L ^a   Ng, C K ^a   Touma, N J ^a   Pus, N J ^a   Hardie, R ^a   Abdelhady, M ^a   Rodrigues, G ^a   Radwan, J ^a   Venkatesan, V ^a   Moussa, M ^a   Downey, D B ^a   Bauman, G ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GOSERELIN; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER STAGING; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOABLATION; CRYOSURGERY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL DISEASE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT DISEASE;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; CRYOSURGERY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOTHERAPY, HIGH-ENERGY; TREATMENT OUTCOME;

EID: 39149143059     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500988     Document Type: Article

References (21)

1. Soaves WA, Gander MJ, Schulman S. Apparatus and techniques for cryosurgery of the prostate. J Urol 1966; 96 508-511.
2. Flocks RH, Nelson C, Boatman DL. Perineal cryosurgery for prostate cancer. J Urol 1972; 108: 933-935.
3. Onik G, Cohen J, Reyes GD, Rubinsky B, Chang Z, Baust J. Tran rectal ultrasound-guided percutaneous radical cryosurgery ablation of the prostate. Cancer 1993; 72: 1291-1299.
4. Shinohara K, Connolly JA, Presti Jr JC, Carroll PR. Cryosurgical treatment of localized prostate cancer (stages T1-T4): Preliminary results. J Urol 1996; 156: 115-121.
5. Miller RJ, Cohen JK, Merlotti LA. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate. Urology 1994; 44: 170-174.
6. Shipley WU, Prout GR, Coachman MM, McManus PL, Healey EA, Althatisen AF et al. Radiation therapy for localized prostate carcinoma: experience of the Massachusetts General Hospital 1973-1981. NCI Monographs 1988; 8: 67-73.
7. Hanks CE. Treatment of earlier stage prostate cancer. In: Devita VT, Hillman S, Rosenberg SA (eds). Radiotherapy. Important Advanced in Oncology. JB Lippincott Company: Philadelphia, 1994, pp 225-239.
8. Pilepich MV, Buzydlowski JW, John MJ, Rubin P, McGowan DG, Marcial VA. A. Phase II trial of hormonal cytoreduction with megestrol and diethylstillbestrol in conjunction with radio-therapy for carcinoma of the prostate: Outcome results of RTOG 83-07. Int J Rad Onc Biol Phys 1995; 32: 175-180.
9. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO et al Long-term result with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomized trial. Lancet 2002; 360: 103-106.
10. Zelefsky MJ, Leibel SA, Burman CM, Kutcher GJ, Harrison A, Happersett L et al. Neoadjuvant hormone therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with 3-dimensional conformal radiation therapy. Int J Rad Onc Biol Phys 1994; 29 755-761.
11. Chin JL, Downey DB, Onik G, Fenster A. 3-dimensional prostate ultrasound and its application to cryosurgery. Tech Urol 1996; 2: 187-193.
12. Chili JL, Downey DB, Mulligan M, Fenster A. A: 3-dimensional transrectal ultrasound guided cryoablation for localized prostate cancer in non-surgical candidates: A. feasibility study and report of early results. J Urol 1998; 159: 910-914.
13. Chin JL, Pautler SE, Mouraviev V, Touma N, Moore K, Downey DB. Results of cryoablation of the prostate after radiation. identifying predictors for treatment failure and complications. J Urol 2001; 165: 1937-1941.
14. ASTRO Consensus Panel. Consensus statement: Guidelines for PSA following radiation therapy. Int J Rad Oncol Biol Phys 1997; 37: 1035.
15. Kuban D, Thamses H, Levy L, Horwitz E, Kupelian P, Martinez A et al Failure definition-dependent differences in outcome following radiation for localized prostate cancer: Can one size fit all? Int J Rad Onc Biol Phys 2005; 61: 409-414.
16. Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V et al. Radiation Therapy Oncology Group. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 2003; 21: 3972-3978.
17. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: High risk patient outcomes. Cancer 2005; 103: 1625-1630.
18. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcome in the primary treatment of prostate cancer. Urology 2002; 60 (2 Suppl 1): 3-11.
19. Donnelly BJ, Saliken JC, Ernst DS, Ali-Ridha N, Brasher PM, Robinson JW et al. Prospective trial of cryosurgical ablation of the prostate: five year results. Urology 2002; 60: 645-649.
20. Ellis DS. Cryosurgery as primary treatment for localized prostate cancer: A community hospital experience. Urology 2002; 60 (2 Suppl 1): 34-39.
21. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA et al Treatment of organ confined prostate cancer with third generation cryosurgery: Preliminary multi-center experience. J Urol 2003; 170: 1126-1130.